ACIU Short Term Debt from 2010 to 2025

ACIU Stock  USD 1.98  0.14  6.60%   
AC Immune Short Term Debt yearly trend continues to be comparatively stable with very little volatility. Short Term Debt is likely to outpace its year average in 2025. From the period from 2010 to 2025, AC Immune Short Term Debt quarterly data regression had r-value of  0.85 and coefficient of variation of  118.20. View All Fundamentals
 
Short Term Debt  
First Reported
2016-06-30
Previous Quarter
694 K
Current Value
M
Quarterly Volatility
8.3 M
 
Covid
Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Interest Expense of 126.3 K, Selling General Administrative of 8.7 M or Total Revenue of 20.1 M, as well as many indicators such as Price To Sales Ratio of 9.38, Dividend Yield of 0.0 or PTB Ratio of 2.28. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
  
Check out the analysis of AC Immune Correlation against competitors.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

Latest AC Immune's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of AC Immune over the last few years. It is AC Immune's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AC Immune's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

ACIU Short Term Debt Regression Statistics

Arithmetic Mean360,144
Geometric Mean0.00
Coefficient Of Variation118.20
Mean Deviation363,662
Median332,000
Standard Deviation425,683
Sample Variance181.2B
Range1.1M
R-Value0.85
Mean Square Error54.1B
R-Squared0.72
Significance0.000031
Slope75,942
Total Sum of Squares2.7T

ACIU Short Term Debt History

20251.1 M
2024M
2023672 K
2022548 K
2021570 K
2020443 K
20191.1 M

About AC Immune Financial Statements

AC Immune shareholders use historical fundamental indicators, such as Short Term Debt, to determine how well the company is positioned to perform in the future. Although AC Immune investors may analyze each financial statement separately, they are all interrelated. The changes in AC Immune's assets and liabilities, for example, are also reflected in the revenues and expenses on on AC Immune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Short Term DebtM1.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.